Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 10/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19547845 | 0.88 | FPR2 (0.49) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL16742520 | 0.87 | FPR2 (0.57) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL16742517 | 0.87 | FPR2 (0.57) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL18086998 | 0.87 | FPR2 (0.50) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL16742494 | 0.86 | FPR2 (0.49) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL16742481 | 0.86 | FPR2 (0.47) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL19563289 | 0.86 | FPR2 (0.47) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL19547869 | 0.86 | FPR2 (0.47) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL18089387 | 0.86 | FPR2 (0.45) | FPR2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL19563271 | 0.86 | FPR2 (0.45) | FPR2RAB9AMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3071548-B1 | PHENYLCARBAMATE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS | ALLERGAN INC (US) | 2017-11-08 | — | — | EP | disclosed |